Pharmaceutical company Zydus on Wednesday announced that it has started the supplies of its COVID-19 vaccine ZyCoV-D to the Government of India against their order from its newly commissioned state-of-the-art, Zydus Vaccine Technology Excellence Centre at the Zydus Biotech Park in Changodar, Ahmedabad.
The company is also planning to make the vaccine available in the private market.
ZyCoV-D is a three-dose vaccine administered intradermally using the painless PharmaJet® needle-free system, Tropis®, on day 0, day 28 and day 56.
The vaccine will be priced at Rs 265 per dose and the applicator being offered at Rs 93 per dose excluding GST
Zydus VTEC manufactures the drug substance for the needle-free DNA Plasmid vaccine, ZyCoV-D. The manufacturing process and in-process material transfers within the plant are automated.
Zydus has also entered into a definitive agreement with Shilpa Medicare Limited, a contract manufacturing organization to produce mutually agreeable doses of ZyCoV-D.
The company also entered into an agreement with Enzychem Lifesciences of the Republic of Korea for the manufacturing license and technology transfer for the Plasmid DNA Vaccine.
These Caramel-Coloured Street Dogs in Brazil Became A National Symbol. Here's Why Big Cat Exchange: Madhya Pradesh To Give 2 Tigers, Get 2 Lions From Gujarat Indian Businessman Ravi Pillai Receives Bahrain's Topmost Award 4-Year-Old Boy Run Over By Speeding Creta In Mumbai, Teen Driver Arrested 2 Dead, Many Feared Trapped For 17 Hours After Mohali Building Collapse Germany Refused To Extradite Saudi Suspect? Suicidal Empathy, Says Elon Musk "Knew What It Took...": Justice Nagarathna's Emotional Tribute To Mother Over 400 More People Arrested In Assam For Child Marriage "Paradise On Earth": Internet Reacts To Heavenly Strawberry Buffet At Seoul Restaurant Track Latest News Live on NDTV.com and get news updates from India and around the world.